LOCAL PROVIDER DIRECTORY
Find a dentist
Search by name or specialty, then choose a city and region or enter a ZIP / postal code.
Choose a location to keep your results local.
Local Health Alerts
What Adults 65 and Older Should Know About the 2025–2026 COVID-19 Vaccine Update
Adults 65 and older remain at highest risk for severe COVID-19. Here’s what the CDC and FDA say about the 2025–2026 vaccine update, how well it protects against hospitalization, and how Medicare covers the cost.
U.S. Drug Shortages in 2026: What the FDA List Means for Patients and How to Protect Your Care
Drug shortages remain a nationwide issue in early 2026. Here’s what it means when a medication appears on the FDA’s Drug Shortages list, how shortages differ from recalls, and what patients should do to protect their care.
FDA Warns About Risks Linked to Compounded GLP-1 Drugs: What Patients Need to Know
The FDA has issued recent safety communications about compounded versions of popular GLP-1 drugs such as semaglutide and tirzepatide, warning of dosing errors, ingredient differences, and potential contamination. Here’s what patients and families should understand about the risks, legal limits, and how to…
What’s New in the 2026 Diabetes Care Guidelines — And What It Means for Patients
The American Diabetes Association’s 2026 Standards of Care update national guidance on glucose monitoring, medications, heart and kidney protection, and mental health screening. Here’s what changed — and what it means for patients across the United States.
Skin Cancer Prevention in 2026: What Federal Health Agencies Want Americans to Know Before UV Season
As spring and summer approach, federal health agencies are reminding Americans that skin cancer is largely preventable. Here’s what the CDC, FDA, USPSTF, and National Cancer Institute say about UV exposure, sunscreen safety, and who should take extra precautions.
Indian Health Service to Phase Out Mercury Dental Fillings by 2027: What Patients Should Know
The Indian Health Service plans to phase out mercury-containing dental amalgam fillings in its facilities by 2027. Here’s what federal agencies say about safety, who may be at higher risk, and whether patients need to remove existing fillings.
Alzheimer’s Antibody Drugs in 2026: What Medicare Covers, Who Qualifies, and What Patients Should Know
Anti-amyloid antibody treatments such as lecanemab are now part of Alzheimer’s care in the United States—but only for certain patients. Here’s who qualifies, what Medicare covers, how MRI safety monitoring works, and what families should realistically expect.
Ransomware in U.S. Hospitals: What Recent Cyberattacks Mean for Patient Safety and Your Medical Records
Federal breach data show ransomware continues to disrupt U.S. hospitals, affecting patient care and exposing medical records. Here’s what that means for your health, privacy, and what you can do if your data are compromised.
Lung Cancer Screening in 2026: Who Should Get a Low-Dose CT and How It Prevents Advanced Disease
If you’re 50 to 80 and have a significant smoking history, you may qualify for annual low-dose CT lung cancer screening. Here’s what the evidence shows, who is eligible, what the trade-offs are, and how insurance coverage works in 2026.
Chiropractic Spinal Manipulation for Chronic Low Back Pain: What the Best Evidence Says in 2026
A major Cochrane review finds that spinal manipulation offers modest relief for chronic low back pain—about similar to exercise and other recommended non-drug treatments. Here’s what that means for patients, safety, Medicare coverage, and when to seek urgent care.
Colorectal Cancer Screening in 2026: Who Should Get Tested, Which Options Are Covered, and What the Latest Guidance Means for You
Colorectal cancer screening now starts at age 45 for most adults. Here’s what current U.S. guidelines say, how stool tests compare with colonoscopy, what happens after a positive result, and what insurance and Medicare typically cover.
Anti-Amyloid Alzheimer’s Drugs in 2026: Who Qualifies, What They Do, and What Families Should Know
FDA-approved anti-amyloid drugs like lecanemab can modestly slow early Alzheimer’s disease—but they are not cures. Here’s who qualifies, what the clinical trials showed, the real risks, and how Medicare coverage works in 2026.